Focus "Rectal cancer": securing excellence beyond the scalpel

Colorectal cancer (CRC) remains one of the most prevalent and lethal malignancies in Switzerland (1). The lifetime-risk of developing CRC is around 4-5% in women and men (2). Early detection of pre-cancerous lesions or early-stage CRC through an effective and high-quality screening program and regular surveillance post-treatment are essential.

Clinical Implementation, Pitfalls and Risks

For nearly two decades, the standard treatment for locally advanced rectal cancer (LARC) involved chemoradiation therapy (CRT) followed by surgery and optional additional chemotherapy. 

If there were no hospitals in Switzerland yet and we could plan a hospital system from scratch, what would it look like? 

The story behind intratumoral budding in rectal cancer